Details of the Drug

General Information of Drug (ID: DMXLILL)

Drug Name

JNJ-63682918

Indication

Disease Entry	ICD 11	Status	REF
Human papillomavirus infection	1A9Y	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03610581) Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix. U.S. National Institutes of Health.